In conclusion, our study described that silencing of TM4SF1 sensitized pancreatic cancer cells via downregulating ABCB1 and ABCC1 to kill by treatment with gemcitabine may be of particular translational significance. The gene discussed is ABCB1; the disease is familial pancreatic carcinoma.